Table of Contents
Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA
Angiogenesis and Antiangiogenesis Agents
Apoptosis, Necrosis, and Autophagy
Bioinformatics
Biomarkers
Cancer Stem Cells
Cell Cycle Regulators
Cellular Responses to Therapy
Chemoprevention
Clinical Trials
DNA Repair and Modulation
Differentiation
Drug Resistance and Modifiers
Epigenetic Targets
Genomics, Proteomics, and Target Discovery
Heat Shock Proteins
Hormonal Agents and Therapy
In vitro and in vivo Models for Targets
MAPK Pathways
Molecular Classification of Tumors
Monoclonal Antibodies
Natural Products
New Molecular Targets
Novel Assay Technology
Pediatric-Early Drug Development
Pharmacogenetics, Pharmacogenomics, and Therapeutic Response
Pharmacokinetics and Pharmacodynamics
Protein-Protein Interaction
RNA and RNA Based Technologies and Therapies
Radiotherapeutics
Regulatory Issues
Signal Transduction Modulators
Target Identification and Validation
Therapeutic Agents: Biological
Therapeutic Agents: Other
Therapeutic Agents: Small Molecule Kinase Inhibitors
Topoisomerase Inhibitors
Tubulin-interacting Agents
Tumor Immunology Targets
Tumor Microenvironment
Tumor Suppressors
Vaccines
November 2011
Volume 10, Issue 11 Supplement
Volume 10, Issue 11 Supplement
Jump to
- Angiogenesis and Antiangiogenesis Agents
- Animal Models
- Apoptosis, Necrosis, and Autophagy
- Bioinformatics
- Biomarkers
- Cancer Stem Cells
- Cell Cycle Regulators
- Cellular Responses to Therapy
- Chemoprevention
- Clinical Trials
- DNA Repair and Modulation
- Differentiation
- Drug Delivery
- Drug Design
- Drug Metabolism, Transport, and Biodistribution
- Drug Resistance and Modifiers
- Drug Screening
- EGFR / Her2
- Epigenetic Targets
- Gene Therapies
- Genomics, Proteomics, and Target Discovery
- Heat Shock Proteins
- Hormonal Agents and Therapy
- Imaging
- In vitro and in vivo Models for Targets
- MAPK Pathways
- Metabolism
- Metastasis and Invasion
- Molecular Classification of Tumors
- Monoclonal Antibodies
- Natural Products
- New Molecular Targets
- Novel Assay Technology
- Other
- Pediatric-Early Drug Development
- Pharmacogenetics, Pharmacogenomics, and Therapeutic Response
- Pharmacokinetics and Pharmacodynamics
- Protein-Protein Interaction
- RNA and RNA Based Technologies and Therapies
- Radiotherapeutics
- Regulatory Issues
- Signal Transduction Modulators
- Target Identification and Validation
- Therapeutic Agents: Biological
- Therapeutic Agents: Other
- Therapeutic Agents: Small Molecule Kinase Inhibitors
- Topoisomerase Inhibitors
- Toxicology
- Tubulin-interacting Agents
- Tumor Immunology Targets
- Tumor Microenvironment
- Tumor Suppressors
- Vaccines
- mTOR / PI3-Kinase
Advertisement
